Literature DB >> 12473557

Ischemic preconditioning suppresses ventricular tachyarrhythmias after myocardial revascularization.

Zhong-Kai Wu1, Tiina Iivainen, Erkki Pehkonen, Jari Laurikka, Matti R Tarkka.   

Abstract

BACKGROUND: Ventricular fibrillation (VF) and tachycardia (VT) are the common and potential life-threatening complications after CABG. Ischemic preconditioning (IP) has been proved effective in reducing ischemia reperfusion arrhythmia in animals and humans. Whether IP is effective in suppressing postoperative VF/VT in patients with CABG has not been studied. METHODS AND
RESULTS: Eighty-six patients with CABG with stable and unstable 3-vessel disease were equally randomly assigned into an IP and a control group. The patients who received IP received 2 periods of 2-minute ischemia followed by 3-minute reperfusion. Twenty-four-hour electrocardiographic data were collected. IP resulted in fewer cases of VF after declamping (48.8% versus 79.1% in IP and control, P=0.004) and a shorter VF period (2.28+/-0.44 versus 4.41+/-0.51 minutes, P=0.002). The episodes of VT were significantly reduced in patients in the IP group during early reperfusion and 24 hours after reperfusion (0.65+/-0.16 versus 3.71+/-0.46, P=0.000 and 0.07+/-0.04 versus 2.12+/-1.41, P=0.002, respectively). De novo sustained VT occurred in 3 control patients as against none in the IP group after surgery. As a result, IP significantly curtailed the mechanical ventilation period and reduced the need for inotropes.
CONCLUSIONS: IP significantly reduced postoperative VF/VT in patients with CABG with 3-vessel disease. Suppression of VT during early reperfusion and 24 hours after reperfusion suggests early and delayed IP phenomena in patients undergoing CABG surgery.

Entities:  

Mesh:

Year:  2002        PMID: 12473557     DOI: 10.1161/01.cir.0000041430.32233.5b

Source DB:  PubMed          Journal:  Circulation        ISSN: 0009-7322            Impact factor:   29.690


  17 in total

Review 1.  [Myocardial preconditioning with volatile anesthetics. General anesthesia as protective intervention?].

Authors:  H Buchinger; U Grundmann; S Ziegeler
Journal:  Anaesthesist       Date:  2005-09       Impact factor: 1.041

2.  The effect of uraemia on the duration of arrhythmias in the context of cardioprotective ischaemic conditioning strategies.

Authors:  Kieran McCafferty; Conor J Byrne; Julius Kieswich; Martin Raftery; Christoph Thiemermann; Muhammad M Yaqoob
Journal:  Heart Asia       Date:  2014-05-24

Review 3.  [Cardioprotection].

Authors:  M Damm; A Hübler; A R Heller
Journal:  Anaesthesist       Date:  2011-11       Impact factor: 1.041

4.  Sevoflurane preconditioning in on-pump coronary artery bypass grafting: a meta-analysis of randomized controlled trials.

Authors:  Yan Lu; Liwei Wang; Na Liu; Tianxin Dong; Ruhong Li
Journal:  J Anesth       Date:  2016-08-16       Impact factor: 2.078

Review 5.  Myocardial ischemic conditioning: Physiological aspects and clinical applications in cardiac surgery.

Authors:  Radhouane Bousselmi; Mohamed Anis Lebbi; Mustapha Ferjani
Journal:  J Saudi Heart Assoc       Date:  2013-11-13

6.  Protein kinase Cepsilon mediates salutary effects on electrical coupling induced by ischemic preconditioning.

Authors:  Thomas J Hund; Deborah L Lerner; Kathryn A Yamada; Richard B Schuessler; Jeffrey E Saffitz
Journal:  Heart Rhythm       Date:  2007-06-08       Impact factor: 6.343

7.  Effect of preconditioning temperature on cardioprotection during global ischemia-reperfusion in the rat heart.

Authors:  Elham A Ghadhanfar; Jasbir S Juggi
Journal:  Exp Clin Cardiol       Date:  2007

Review 8.  Preconditioning in humans.

Authors:  Shereif H Rezkalla; Robert A Kloner
Journal:  Heart Fail Rev       Date:  2007-12       Impact factor: 4.214

9.  Determinants of delayed preconditioning against myocardial stunning in chronically-instrumented pigs.

Authors:  James A Fallavollita
Journal:  J Cardiovasc Transl Res       Date:  2009-03       Impact factor: 4.132

10.  Pre-infarction angina and outcomes in non-ST-segment elevation myocardial infarction: data from the RICO survey.

Authors:  Luc Lorgis; Aurélie Gudjoncik; Carole Richard; Laurent Mock; Philippe Buffet; Philippe Brunel; Luc Janin-Manificat; Jean-Claude Beer; Damien Brunet; Claude Touzery; Luc Rochette; Yves Cottin; Marianne Zeller
Journal:  PLoS One       Date:  2012-12-18       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.